| Literature DB >> 34020759 |
Chiranjit Ghosh1, Armando Leon1, Seena Koshy1, Obadah Aloum1, Yazan Al-Jabawi1, Nour Ismail1, Zoe Freeman Weiss2, Sophia Koo3.
Abstract
Various analytical methods can be applied to concentrate, separate, and examine trace volatile organic metabolites in the breath, with the potential for noninvasive, rapid, real-time identification of various disease processes, including an array of microbial infections. Although biomarker discovery and validation in microbial infections can be technically challenging, it is an approach that has shown great promise, especially for infections that are particularly difficult to identify with standard culture and molecular amplification-based approaches. This article discusses the current state of breath analysis for the diagnosis of infectious diseases.Entities:
Keywords: Biomarker; Breath; Diagnosis; Metabolites; Noninvasive; Point-of-care; VOC
Mesh:
Substances:
Year: 2021 PMID: 34020759 PMCID: PMC8141093 DOI: 10.1016/j.cll.2021.03.002
Source DB: PubMed Journal: Clin Lab Med ISSN: 0272-2712 Impact factor: 2.172